Physiology and pharmacology of glucagon-like peptide-1 receptor

• Main Authors: D. V. Kurkin (Author), D. A. Bakulin (Author), E. I. Morkovin (Author), V. I. Petrov (Author), A. V. Strygin (Author), K. N. Koryanova (Author), Yu. V. Gorbunova (Author), Yu. A. Kolosov (Author), O. V. Ivanova (Author), E. V. Pavlova (Author), M. A. Dzhavakhyan (Author), A. V. Zaborovsky (Author), V. B. Saparova (Author), I. E. Makarenko (Author), R. I. Drai (Author), A. N. Chumachenko (Author)
• Formato: Libro
• Publicado: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2024-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Modern approaches to the treatment of type 2 diabetes mellitus (T2DM) are aimed not only at glycemic control, but also at reducing cardiovascular risks. The increasing prevalence of the disease and the need for effective treatment options highlight the importance of glucagon-like peptide-1 (GLP-1) r...